Avenue Therapeutics (ATXI) Institutional Ownership $0.22 0.00 (0.00%) As of 05/21/2025 01:12 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Avenue Therapeutics (NASDAQ:ATXI)CurrentInstitutional OwnershipPercentage17.34%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$372.07KNumber ofInstitutional Sellers(last 12 months)0 Get ATXI Insider Trade Alerts Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATXI Institutional Buying and Selling by Quarter Avenue Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 Boothbay Fund Management LLC41,089$82K0.0%N/A2.004% 10/18/2024 Moss Adams Wealth Advisors LLC11,000$27K0.0%N/A1.169% 8/15/2024 Armistice Capital LLC75,000$262K0.0%N/A7.970% 1/28/2022National Asset Management Inc.71,338$65K0.0%-20.1%0.376% 11/16/2021National Asset Management Inc.89,237$133K0.0%-29.2%0.531% 10/19/2021 Kestra Advisory Services LLC22,500$34K0.0%N/A0.134% 9/17/2021 Virtu Financial LLC26,373$66K0.0%N/A0.157% 9/3/2021Parametric Portfolio Associates LLC10,554$26K0.0%-59.2%0.063% 8/16/2021 Occudo Quantitative Strategies LP14,398$36K0.0%N/A0.086% 8/13/2021 Renaissance Technologies LLC78,314$197K0.0%N/A0.468% Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/13/2021 Northern Trust Corp13,767$35K0.0%-82.1%0.082% 8/13/2021 Geode Capital Management LLC79,556$199K0.0%-40.0%0.475% 8/13/2021 Vanguard Group Inc.449,982$1.13M0.0%-35.5%2.687% 8/12/2021 XTX Topco Ltd10,864$27K0.0%N/A0.065% 8/12/2021 Advisory Services Network LLC35,121$88K0.0%N/A0.210% 8/12/2021Ergoteles LLC30,400$76K0.0%N/A0.182% 8/10/2021National Asset Management Inc.126,037$317K0.0%-26.1%0.753% 5/20/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060% 5/19/2021 Squarepoint Ops LLC11,668$71K0.0%N/A0.070% 5/17/2021 Goldman Sachs Group Inc.17,319$105K0.0%N/A0.103% 5/13/2021 Trexquant Investment LP13,874$84K0.0%N/A0.083% 5/13/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060% 5/13/2021 Barclays PLC5,568$34K0.0%+159.0%0.033% 5/12/2021 Northern Trust Corp77,049$467K0.0%-6.8%0.460% 5/12/2021 Geode Capital Management LLC132,594$804K0.0%+5.9%0.792% (Data available from 1/1/2016 forward) ATXI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATXI shares? During the previous two years, the following institutional investors and hedge funds held shares of Avenue Therapeutics shares: Armistice Capital LLC ($262K), and Boothbay Fund Management LLC ($82K), Moss Adams Wealth Advisors LLC ($27K).Learn more on ATXI's institutional investors. What percentage of Avenue Therapeutics stock is owned by institutional investors? 17.34% of Avenue Therapeutics stock is owned by institutional investors. Learn more on ATXI's institutional investor holdings. Which institutional investors have been buying Avenue Therapeutics stock? The following institutional investors have purchased Avenue Therapeutics stock in the last 24 months: Armistice Capital LLC ($75K), Boothbay Fund Management LLC ($41.09K), and Moss Adams Wealth Advisors LLC ($11K). How much institutional buying is happening at Avenue Therapeutics? Institutional investors have bought a total of 127,089 shares in the last 24 months. This purchase volume represents approximately $372.07K in transactions. Related Companies GRI Bio Major Shareholders PowerUp Acquisition Major Shareholders InMed Pharmaceuticals Major Shareholders Qualigen Therapeutics Major Shareholders Vaccinex Major Shareholders Palatin Technologies Major Shareholders Aspira Women's Health Major Shareholders Aptevo Therapeutics Major Shareholders Galmed Pharmaceuticals Major Shareholders Elevai Labs Major Shareholders This page (NASDAQ:ATXI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
